1. Home
  2. VLY vs DAWN Comparison

VLY vs DAWN Comparison

Compare VLY & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valley National Bancorp

VLY

Valley National Bancorp

HOLD

Current Price

$11.92

Market Cap

5.2B

Sector

Finance

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$9.63

Market Cap

624.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLY
DAWN
Founded
1927
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
624.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
VLY
DAWN
Price
$11.92
$9.63
Analyst Decision
Buy
Strong Buy
Analyst Count
16
9
Target Price
$13.00
$26.56
AVG Volume (30 Days)
6.8M
3.1M
Earning Date
01-22-2026
11-04-2025
Dividend Yield
3.64%
N/A
EPS Growth
40.78
N/A
EPS
0.88
N/A
Revenue
$1,704,193,000.00
$133,672,000.00
Revenue This Year
$33.72
$15.51
Revenue Next Year
$10.10
$49.99
P/E Ratio
$13.74
N/A
Revenue Growth
8.06
31.11
52 Week Low
$7.48
$5.64
52 Week High
$12.18
$13.53

Technical Indicators

Market Signals
Indicator
VLY
DAWN
Relative Strength Index (RSI) 65.73 59.54
Support Level $11.93 $8.13
Resistance Level $12.15 $10.47
Average True Range (ATR) 0.22 0.63
MACD 0.01 0.11
Stochastic Oscillator 69.39 67.51

Price Performance

Historical Comparison
VLY
DAWN

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: